Recommended dosage and standard dosage of imatinib

Imatinib/Gleevec (Imatinib) is an oral targeted therapy. Its dosage and administration method depend on the specific treatment object and the patient's condition. The recommended starting dose of imatinib may vary for different types of tumors, but in most cases, imatinib use follows a standard dosing regimen to maximize treatment effectiveness and reduce side effects.

In the treatment of chronic myelogenous leukemia (CML), the usual recommended starting dose of imatinib is 400 mg once daily. This dose is suitable for most adult patients and is usually taken after a meal to reduce stomach irritation. For those patients with more severe conditions or high-grade leukemia, doctors may adjust the dose appropriately based on the patient's specific situation. In some cases, after a period of treatment, if a patient's condition is not adequately controlled, doctors may increase the dose of imatinib, up to 800 mg daily.

For patients with gastrointestinal stromal tumors (GIST), the recommended starting dose of imatinib is also 400 mg once daily. Similar to CML, patients with GIST should also take this drug after meals to increase the bioavailability of the drug. During the early stages of treatment, patients should receive regular imaging studies and blood tests to monitor the effectiveness of treatment and potential side effects. If the patient tolerates imatinib well and the disease is under control, the treatment dose generally does not change much. However, for some patients who are resistant or progress rapidly, doctors may recommend increasing the dose or changing the treatment plan.

When using imatinib, patients must follow the doctor's instructions and ensure that the drug is taken regularly. Regular blood tests and health monitoring are critical to patient treatment. If serious side effects or discomfort occur, you should contact your doctor promptly so that the treatment plan can be adjusted or the side effects can be dealt with.

Reference materials:https://www.gleevec.com/